Clinical factors affecting quality of the response to Stelara for psoriasis

[Bill]

Nothing illogical. Patients with several risk factors are less likely to respond well to treatment than those with none or one. And with such a small number you need to set the bar high else there is no one to study.

I dont think the health funds will be using this study as ammo, albeit from my <$20 per year unsubsidised drug cost perspective.

Cheers,

Bill